Affiliation:
1. Department of Community and Behavioral Health, College of Public Health University of Iowa Iowa City Iowa USA
2. Department of Preventive and Community Dentistry, College of Dentistry University of Iowa Iowa City Iowa USA
3. Department of Internal Medicine, Carver College of Medicine University of Iowa Iowa City Iowa USA
Abstract
AbstractObjectivesWith rates of the human papillomavirus (HPV) vaccination remaining low and rates of oropharyngeal cancer rising, engaging new partners to promote vaccination is necessary. We aimed to identify dental hygienists' and dentists' knowledge about HPV, the HPV vaccine, and preferences for continuing education.MethodsThis mixed‐methods study recruited dental hygienists and dentists working in private practice in Iowa to participate in a mailed cross‐sectional survey (dental hygienists) and qualitative telephone interviews (dental hygienists and dentists). Survey and interview topics included existing knowledge about HPV vaccination, HPV vaccination promotion efforts, barriers to HPV vaccine promotion, and preferences for continuing education (CE).ResultsWe received 470 surveys from dental hygienists (response rate = 22.6%) and interviewed 19 dental hygienists and 20 dentists. Vaccine efficacy and safety, along with communication strategies, were key topics of interest for CE. Dental hygienists' most commonly identified barriers were lack of knowledge (67%) and low comfort levels (42%).ConclusionsKnowledge was identified as a key barrier to providing a strong recommendation for HPV vaccination and convenience was the most important factor to consider for any future CE. Our team is in the process of designing a CE course based on this information to help dental professionals effectively engage in HPV vaccine promotion in their practices.
Funder
Centers for Disease Control and Prevention
Subject
Public Health, Environmental and Occupational Health,General Dentistry
Reference32 articles.
1. American Dental Association [Internet].Cancer (head and neck).2020. [cited 2021 Aug 24] Available fromhttps://www.ada.org/en/member-center/oral-health-topics/cancer-head-and-neck
2. Centers for Disease Control and Prevention [Internet].How many cancers are linked with HPV each year?2019. [cited 2021 Aug 25] Available fromhttps://www.cdc.gov/cancer/hpv/statistics/cases.htm
3. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
4. Merck [Internet].FDA approves Merck's GARDASIL 9 for the prevention of certain HPV‐related head and neck cancers.2020. [cited 2021 Aug 25]. Available fromhttps://www.merck.com/news/fda-approves-mercks-gardasil-9-for-the-prevention-of-certain-hpv-related-head-and-neck-cancers/